AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|
27.6 C
New York
Monday, June 29, 2026

Tag: patient

Elevate Your Portfolio: Top 3 Dow Stocks Women Should Watch for 2025 Success

Hey, fabulous financial friends! 🚀 Ready to shake up your investment strategy? Let's dive into why it might be time to swap those risky...

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

Basel, 28 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey. 

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

HIMS STOCK UPDATE: Hims & Hers Health, Inc. (NYSE:HIMS) is being Sued for Securities Fraud – Contact BFA Law by August 25 Class Action...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

REPL CLASS ACTION ALERT: FDA Response Letter Leads to Replimune Group, Inc. Class Action – Investors are Notified to Contact BFA Law by September...

Replimune Group, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Caribou (CRBU) To Contact Him Directly To Discuss Their Options

Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report — Hagens Berman

SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.

PharmAla Issues Q3 Financial Statements

PharmAla releases Q3 financials showing increased customer deposit and SAP sales growth

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the “Reverse Stock Split”). The Company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of “CLDI.” The new CUSIP number for the Company’s common stock following the Reverse Stock Split will be 320703 408.

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.

Movement Room Hits 250 Google 5-Star Reviews, Cementing Position as Best Physiotherapy Clinic in Vancouver

Vancouver, BC, July 25, 2025 (GLOBE NEWSWIRE) -- Movement Room – Physiotherapy East Vancouver proudly announces its latest achievement of 250 5-star reviews on Google, further solidifying its reputation as the best physiotherapy clinic in Vancouver. Conveniently located at 5334 Victoria Dr, Vancouver, BC V5P 3V7, the clinic is known for its expertise in physiotherapy, massage therapy, kinesiology, and ICBC injury rehabilitation, helping thousands of Vancouver residents recover from injuries, manage chronic pain, and restore their physical health.

Matrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic Offerings

Leader In Delivering Home-Based Health and Care Services Partners with Laboratory Known for Quality, Reliability and Innovation NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Matrix Medical...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient